| Name of the Instrument/Tool | Visual Analogue Scale of the Fibromyalgia Impact Questionnaire (VASFIQ) |
| First Description |
Boomershine CS, Emir B, Wang Y, Zlateva G. Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale. Ther Adv Musculoskelet Dis. 2011;3(5):215-26. Epub 2012/08/08. |
| Year | 2011 |
| Domains | |
| Concept of constructs | Global assessment |
| Population/Disease | Disease specific |
| Originally developed for | Fibromyalgia (FM) |
| Other rheumatic diseases where can be applied (only if validated) |
--- |
| Additional population with no rheumatic diseases |
No |
| Language: Originally published in | English |
| Available in Language | Spanish |
| REFERENCE IDENTIFICATION | |
| Author/s | Boomershine CS, Emir B, Wang Y, Zlateva G |
| Title | Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale |
| Journal | Ther Adv Musculoskelet Dis |
| Year | 2011 |
| Vol | 3 |
| Num | 5 |
| Pages | 215-26 |
| Country | United States |
| Language | English |
| Other references of interest | |
| No other References. | |
| Instrument/Tool Translations References | |
| No other References. | |
| DEVELOPER CONTACT INFORMATION | |
| Correspondence to | Chad S. Boomershine |
| chad.boomershine@vanderbilt.edu | |
| Address | Department of Medicine, Vanderbilt University, T3219 MCN, 1161 21st Avenue South, Nashville, TN 37232, USA |
| Website | --- |
| Available | --- |
| Links | --- |
| DESCRIPTION OF THE INSTRUMENT | |
| Type Of Measure | Composite Index |
| Brief Description |
A VAS + FIQ that quantify symptom severity of FM patient, designed for clinical use. It provides a mechanism for patients to effectively articulate their symptom burden to make diagnostic and treatment decision more accurate. |
| Number of Items | 7 |
| Range | 0-70 |
| Responses options/scale |
No |
| Developed for | Clinical practice |
| PRACTICAL APPLICATION | |
| Method of administration | Self-administered |
| Recommendations to score | --- |
| Score Interpretation | --- |
| Cut-off points | uses the full length questionnaire as reference |
| Cut-off points applied to | --- |
| Smallest detectable change if described | --- |
| Smallest detectable change applied to | Not specified |
| Completion time by the patient | 5 minutes |
| Scoring time by the assessor | 0 minutes |
| Training to score | initial training is required to ensure accurate self-completion of questionnaire. |
| Strengths | --- |
| Limitations | --- |
| OTHER COMMENTS | |
| Other Comments |
VASFIQ should not be used in isolation to make treatment decisions. But it is a rapid screen that can quantify symptom severity, but it is not intended for use as a diagnostic instrument.
A careful clinical evaluation is required to identify the underlying cause of symptoms and determine the most appropriate course of therapy. It also can improve FM management by providing a mechanism for patients to effectively articulate their symptom burden and enhance the ability of clinicians to interpret the patient's complaints into a coherent intellectual framework from which to make diagnostic and treatment decisions. |